At the center of the circle: Purinergic signaling in the autocrine loops of pancreatic islets

Wiley Interdisciplinary Reviews: Membrane Transport and Signaling

Volumn 2, Issue 3, 2013, Pages 107-119

  Öhman, Jenny ^a   Erlinge, David ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; G PROTEIN COUPLED RECEPTOR; GLUCOSE; INSULIN; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC P2Y14 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GLUCOSE; URIDINE TRIPHOSPHATE;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE RELEASE; HUMAN; HYDROLYSIS; INFLAMMATION; INSULIN RELEASE; INTRACELLULAR SIGNALING; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET DELTA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84879193007     PISSN: 2190460X     EISSN: 21904618     Source Type: Journal    
DOI: 10.1002/wmts.82     Document Type: Article

References (93)

1. Rodriguez Candela JL, Garcia-Fernandez MC. Stimulation of secretion of insulin by adenosine-triphosphate. Nature 1963, 197:1210.
2. Levine RA, Oyama S, Kagan A, Glick SM. Stimulation of insulin and growth hormone secretion by adenine nucleotides in primates. J Lab Clin Med 1970, 75:30-36.
3. Leitner JW, Sussman KE, Vatter AE, Schneider FH. Adenine nucleotides in the secretory granule fraction of rat islets. Endocrinology 1975, 96:662-677.
4. Loubatieres-Mariani MM, Chapal J, Lignon F, Valette G. Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur J Pharmacol 1979, 59:277-286.
5. Chapal J, Loubatieres-Mariani MM, Roye M. Effect of adenosine and phosphated derivatives on insulin release from the newborn dog pancreas. J Physiol (Paris) 1981, 77:873-875.
6. Petit P, Manteghetti M, Puech R, Loubatieres-Mariani MM. ATP and phosphate-modified adenine nucleotide analogues. Effects on insulin secretion and calcium uptake. Biochem Pharmacol 1987, 36:377-380.
7. Chapal J, Loubatieres-Mariani MM. Attempt to antagonized the stimulatory effect or ATP on insulin secretion. Eur J Pharmacol 1981, 74:127-134.
8. Chapal J, Loubatieres-Mariani MM. Effects of phosphate-modified adenine nucleotide analogues on insulin secretion from perfused rat pancreas. Br J Pharmacol 1981, 73:105-110.
9. Bacher S, Kraupp O, Conca W, Raberger G. The effects of NECA (adenosine-5′N-ethylcarboxamide) and of adenosine on glucagon and insulin release from the in situ isolated blood-perfused pancreas in anesthetized dogs. Naunyn Schmiedebergs Arch Pharmacol 1982, 320:67-71.
10. Campbell IL, Taylor KW. Effects of adenosine, 2-deoxyadenosine and N6-phenylisopropyladenosine on rat islet function and metabolism. Biochem J 1982, 204:689-696.
11. Chapal J, Loubatieres-Mariani MM, Petit P, Roye M. Evidence for an A2-subtype adenosine receptor on pancreatic glucagon secreting cells. Br J Pharmacol 1985, 86:565-569.
12. Hillaire-Buys D, Bertrand G, Gross R, Loubatieres-Mariani MM. Evidence for an inhibitory A1 subtype adenosine receptor on pancreatic insulin-secreting cells. Eur J Pharmacol 1987, 136:109-112.
13. Jacques-Silva MC, Correa-Medina M, Cabrera O, Rodriguez-Diaz R, Makeeva N, Fachado A, Diez J, Berman DM, Kenyon NS, Ricordi C, et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic β cell. Proc Natl Acad Sci U S A 2010, 107:6465-6470.
14. Petit P, Bertrand G, Schmeer W, Henquin JC. Effects of extracellular adenine nucleotides on the electrical, ionic and secretory events in mouse pancreatic β-cells. Br J Pharmacol 1989, 98:875-882.
15. Poulsen CR, Bokvist K, Olsen HL, Hoy M, Capito K, Gilon P, Gromada J. Multiple sites of purinergic control of insulin secretion in mouse pancreatic β-cells. Diabetes 1999, 48:2171-2181.
16. Novak I. Purinergic receptors in the endocrine and exocrine pancreas. Purinergic Signal 2008, 4:237-253.
17. Petit P, Lajoix AD, Gross R. P2 purinergic signalling in the pancreatic β-cell: control of insulin secretion and pharmacology. Eur J Pharm Sci 2009, 37:67-75.
18. Bertrand G, Chapal J, Loubatieres-Mariani MM, Roye M. Evidence for two different P2-purinoceptors on β cell and pancreatic vascular bed. Br J Pharmacol 1987, 91:783-787.
19. Blachier F, Malaisse WJ. Effect of exogenous ATP upon inositol phosphate production, cationic fluxes and insulin release in pancreatic islet cells. Biochim Biophys Acta 1988, 970:222-229.
20. Hellman B. Pulsatility of insulin release-a clinically important phenomenon. Ups J Med Sci 2009, 114:193-205.
21. Geschwind JF, Hiriart M, Glennon MC, Najafi H, Corkey BE, Matschinsky FM, Prentki M. Selective activation of Ca2+ influx by extracellular ATP in a pancreatic β-cell line (HIT). Biochim Biophys Acta 1989, 1012:107-115.
22. Gylfe E, Hellman B. External ATP mimics carbachol in initiating calcium mobilization from pancreatic β-cells conditioned by previous exposure to glucose. Br J Pharmacol 1987, 92:281-289.
23. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 1985, 16:433-440.
24. Petit P, Manteghetti M, Loubatieres-Mariani MM. Differential effects of purinergic and cholinergic activation on the hydrolysis of membrane polyphosphoinositides in rat pancreatic islets. Biochem Pharmacol 1988, 37:1213-1217.
25. Arkhammar P, Hallberg A, Kindmark H, Nilsson T, Rorsman P, Berggren PO. Extracellular ATP increases cytoplasmic free Ca2+ concentration in clonal insulin-producing RINm5F cells. A mechanism involving direct interaction with both release and refilling of the inositol 1, 4, 5-trisphosphate-sensitive Ca2+ pool. Biochem J 1990, 265:203-211.
26. Gong Q, Kakei M, Koriyama N, Nakazaki M, Morimitsu S, Yaekura K, Tei C. P2Y-purinoceptor mediated inhibition of L-type Ca2+ channels in rat pancreatic β-cells. Cell Struct Funct 2000, 25:279-289.
27. Zhao YF, Xu R, Hernandez M, Zhu Y, Chen C. Distinct intracellular Ca2+ response to extracellular adenosine triphosphate in pancreatic β-cells in rats and mice. Endocrine 2003, 22:185-192.
28. Li GD, Milani D, Dunne MJ, Pralong WF, Theler JM, Petersen OH, Wollheim CB. Extracellular ATP causes Ca2(+)-dependent and -independent insulin secretion in RINm5F cells. Phospholipase C mediates Ca2+ mobilization but not Ca2+ influx and membrane depolarization. J Biol Chem 1991, 266:3449-3457.
29. Silva AM, Rodrigues RJ, Tome AR, Cunha RA, Misler S, Rosario LM, Santos RM. Electrophysiological and immunocytochemical evidence for P2X purinergic receptors in pancreatic β cells. Pancreas 2008, 36:279-283.
30. Chevassus H, Roig A, Belloc C, Lajoix AD, Broca C, Manteghetti M, Petit P. P2Y receptor activation enhances insulin release from pancreatic β-cells by triggering the cyclic AMP/protein kinase A pathway. Naunyn Schmiedebergs Arch Pharmacol 2002, 366:464-469.
31. Ribes G, Bertrand G, Petit P, Loubatieres-Mariani MM. Effects of 2-methylthio ATP on insulin secretion in the dog in vivo. Eur J Pharmacol 1988, 155:171-174.
32. Hillaire-Buys D, Bertrand G, Chapal J, Puech R, Ribes G, Loubatieres-Mariani MM. Stimulation of insulin secretion and improvement of glucose tolerance in rat and dog by the P2y-purinoceptor agonist, adenosine-5′-O-(2-thiodiphosphate). Br J Pharmacol 1993, 109:183-187.
33. Hillaire-Buys D, Gross R, Pares-Herbute N, Ribes G, Loubatieres-Mariani MM. In vivo and in vitro effects of adenosine-5′-O-(2-thiodiphosphate) on pancreatic hormones in dogs. Pancreas 1994, 9:646-651.
34. Bertrand G, Chapal J, Puech R, Loubatieres-Mariani MM. Adenosine-5′-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas. Br J Pharmacol 1991, 102:627-630.
35. Chapal J, Hillaire-Buys D, Bertrand G, Pujalte D, Petit P, Loubatieres-Mariani MM. Comparative effects of adenosine-5′-triphosphate and related analogues on insulin secretion from the rat pancreas. Fundam Clin Pharmacol 1997, 11:537-545.
36. Petit P, Hillaire-Buys D, Manteghetti M, Debrus S, Chapal J, Loubatieres-Mariani MM. Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell. Br J Pharmacol 1998, 125:1368-1374.
37. Wang CZ, Namba N, Gonoi T, Inagaki N, Seino S. Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. Biochem Biophys Res Commun 1996, 220:196-202.
38. Ohtani M, Suzuki J, Jacobson KA, Oka T. Evidence for the possible involvement of the P2Y(6) receptor in Ca (2+) mobilization and insulin secretion in mouse pancreatic islets. Purinergic Signal 2008, 4:365-375.
39. Balasubramanian R, Ruiz de Azua I, Wess J, Jacobson KA. Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic β cells. Biochem Pharmacol 2010, 79:1317-1326.
40. Parandeh F, Abaraviciene SM, Amisten S, Erlinge D, Salehi A. Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors. Biochem Biophys Res Commun 2008, 370:499-503.
41. Sassmann A, Gier B, Grone HJ, Drews G, Offermanns S, Wettschureck N. The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice. J Clin Invest 2010, 120:2184-2193.
42. Fischer B, Chulkin A, Boyer JL, Harden KT, Gendron FP, Beaudoin AR, Chapal J, Hillaire-Buys D, Petit P. 2-Thioether 5′-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-receptors. J Med Chem 1999, 42:3636-3646.
43. Leon C, Freund M, Latchoumanin O, Farret A, Petit P, Cazenave JP, Gachet C. The P2Y(1) receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice. Purinergic Signal 2005, 1:145-151.
44. Farret A, Filhol R, Linck N, Manteghetti M, Vignon J, Gross R, Petit P. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5′-O-(1-boranotriphosphate)-adenosine analogues. Pharm Res 2006, 23:2665-2671.
45. Amisten S, Meidute-Abaraviciene S, Tan C, Olde B, Lundquist I, Salehi A, Erlinge D. ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice. Diabetologia 2010, 53:1927-1934.
46. Verspohl EJ, Johannwille B, Waheed A, Neye H. Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets. Can J Physiol Pharmacol 2002, 80:562-568.
47. Santini E, Cuccato S, Madec S, Chimenti D, Ferrannini E, Solini A. Extracellular adenosine 5′-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype. Endocrinology 2009, 150:2596-2602.
48. Ohtani M, Ohura K, Oka T. Involvement of P2X receptors in the regulation of insulin secretion, proliferation and survival in mouse pancreatic β-cells. Cell Physiol Biochem 2011, 28:355-366.
49. Squires PE, James RF, London NJ, Dunne MJ. ATP-induced intracellular Ca2+ signals in isolated human insulin-secreting cells. Pflugers Arch 1994, 427:181-183.
50. Fernandez-Alvarez J, Hillaire-Buys D, Loubatieres-Mariani MM, Gomis R, Petit P. P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas 2001, 22:69-71.
51. Richards-Williams C, Contreras JL, Berecek KH, Schwiebert EM. Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet β-cells to potentiate insulin secretion. Purinergic Signal 2008, 4:393-405.
52. Coutinho-Silva R, Parsons M, Robson T, Burnstock G. Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing. Cell Tissue Res 2001, 306:373-383.
53. Lee DH, Park KS, Kim DR, Lee JW, Kong ID. Dual effect of ATP on glucose-induced insulin secretion in HIT-T15 cells. Pancreas 2008, 37:302-308.
54. Glas R, Sauter NS, Schulthess FT, Shu L, Oberholzer J, Maedler K. Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and β cell function and survival. Diabetologia 2009, 52:1579-1588.
55. Lugo-Garcia L, Filhol R, Lajoix AD, Gross R, Petit P, Vignon J. Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma β-cells: a molecular and binding characterization. Eur J Pharmacol 2007, 568:54-60.
56. Lugo-Garcia L, Nadal B, Gomis R, Petit P, Gross R, Lajoix AD. Human pancreatic islets express the purinergic P2Y11 and P2Y12 receptors. Horm Metab Res 2008, 40:827-830.
57. Chapal J, Loubatieres-Mariani MM, Roye M, Zerbib A. Effects of adenosine, adenosine triphosphate and structural analogues on glucagon secretion from the perfused pancreas of rat in vitro. Br J Pharmacol 1984, 83:927-933.
58. Bertrand G, Gross R, Ribes G, Loubatieres-Mariani MM. P2 purinoceptor agonists stimulate somatostatin secretion from dog pancreas. Eur J Pharmacol 1990, 182:369-373.
59. Tuduri E, Filiputti E, Carneiro EM, Quesada I. Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic α-cells by extracellular ATP and purinergic receptors. Am J Physiol Endocrinol Metab 2008, 294:E952-E960.
60. Coutinho-Silva R, Robson T, Beales PE, Burnstock G. Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes. Autoimmunity 2007, 40:108-116.
61. Salehi A, Qader SS, Grapengiesser E, Hellman B. Pulses of somatostatin release are slightly delayed compared with insulin and antisynchronous to glucagon. Regul Pept 2007, 144:43-49.
62. Feldman JM, Jackson TB. Specificity of nucleotide-induced insulin secretion. Endocrinology 1974, 94:388-394.
63. Jain K, Logothetopoulos J. Metabolic signals produced by purine ribonucleosides stimulate proinsulin biosynthesis and insulin secretion. Biochem J 1978, 170:461-467.
64. Andersson A. Nucleoside-stimulated insulin production by isolated mouse pancreatic islets. Horm Metab Res Suppl 1980, suppl 10:14-19.
65. Ismail NA, El Denshary EE, Montague W. Adenosine and the regulation of insulin secretion by isolated rat islets of Langerhans. Biochem J 1977, 164:409-413.
66. Bertrand G, Nenquin M, Henquin JC. Comparison of the inhibition of insulin release by activation of adenosine and α 2-adrenergic receptors in rat β-cells. Biochem J 1989, 259:223-228.
67. Bertrand G, Petit P, Bozem M, Henquin JC. Membrane and intracellular effects of adenosine in mouse pancreatic β-cells. Am J Physiol 1989, 257(4 Pt 1):E473-E478.
68. Johansson SM, Salehi A, Sandstrom ME, Westerblad H, Lundquist I, Carlsson PO, Fredholm BB, Katz A. A1 receptor deficiency causes increased insulin and glucagon secretion in mice. Biochem Pharmacol 2007, 74:1628-1635.
69. Grapengiesser E, Gylfe E, Hellman B. Synchronization of glucose-induced Ca2+ transients in pancreatic β-cells by a diffusible factor. Biochem Biophys Res Commun 1999, 254:436-439.
70. Grapengiesser E, Dansk H, Hellman B. External ATP triggers Ca2+ signals suited for synchronization of pancreatic β-cells. J Endocrinol 2005, 185:69-79.
71. Hellman B, Dansk H, Grapengiesser E. Pancreatic β-cells communicate via intermittent release of ATP. Am J Physiol Endocrinol Metab 2004, 286:E759-E765.
72. Grapengiesser E, Dansk H, Hellman B. Pulses of external ATP aid to the synchronization of pancreatic β-cells by generating premature Ca(2+) oscillations. Biochem Pharmacol 2004, 68:667-674.
73. Salehi A, Qader SS, Grapengiesser E, Hellman B. Inhibition of purinoceptors amplifies glucose-stimulated insulin release with removal of its pulsatility. Diabetes 2005, 54:2126-1231.
74. Grapengiesser E, Salehi A, Qader SS, Hellman B. Glucose induces glucagon release pulses antisynchronous with insulin and sensitive to purinoceptor inhibition. Endocrinology 2006, 147:3472-3477.
75. Salehi A, Parandeh F, Fredholm BB, Grapengiesser E, Hellman B. Absence of adenosine A1 receptors unmasks pulses of insulin release and prolongs those of glucagon and somatostatin. Life Sci 2009, 85:470-476.
76. Grapengiesser E, Dansk H, Hellman B. Synchronization of pancreatic β-cell rhythmicity after glucagon induction of Ca2+ transients. Cell Calcium 2003, 34:49-53.
77. Bodin P, Burnstock G. Purinergic signalling: ATP release. Neurochem Res 2001, 26:959-969.
78. Detimary P, Jonas JC, Henquin JC. Stable and diffusible pools of nucleotides in pancreatic islet cells. Endocrinology 1996, 137:4671-4676.
79. Detimary P, Jonas JC, Henquin JC. Possible links between glucose-induced changes in the energy state of pancreatic B cells and insulin release. Unmasking by decreasing a stable pool of adenine nucleotides in mouse islets. J Clin Invest 1995, 96:1738-1745.
80. Obermuller S, Lindqvist A, Karanauskaite J, Galvanovskis J, Rorsman P, Barg S. Selective nucleotide-release from dense-core granules in insulin-secreting cells. J Cell Sci 2005, 118(Pt 18):4271-4282.
81. Hutton JC, Penn EJ, Peshavaria M. Low-molecular-weight constituents of isolated insulin-secretory granules. Bivalent cations, adenine nucleotides and inorganic phosphate. Biochem J 1983, 210:297-305.
82. Hazama A, Hayashi S, Okada Y. Cell surface measurements of ATP release from single pancreatic β cells using a novel biosensor technique. Pflugers Arch 1998, 437:31-35.
83. Braun M, Wendt A, Karanauskaite J, Galvanovskis J, Clark A, MacDonald PE, Rorsman P. Corelease and differential exit via the fusion pore of GABA, serotonin, and ATP from LDCV in rat pancreatic β cells. J Gen Physiol 2007, 129:221-231.
84. Karanauskaite J, Hoppa MB, Braun M, Galvanovskis J, Rorsman P. Quantal ATP release in rat β-cells by exocytosis of insulin-containing LDCVs. Pflugers Arch 2009, 458:389-401.
85. Hellerstroem C, Taeljedal IB, Hellman B. Quantitative studies on isolated pancreatic islets of mammals. 5-Nucleotidase and adenosine triphosphatase activities in normal and cortisone-treated rats. Endocrinology 1965, 76:315-322.
86. Taeljedal IB, Hellman B, Hellerstroem C. Quantitative studies on isolated pancreatic islets of mammals: adenosine triphosphatase activity in normal and obese-hyperglycemic mice. J Histochem Cytochem 1964, 12:491-497.
87. Taljedal IB, Hellman B, Hellerstrom C. Quantitative studies on isolated pancreatic islets of mammals: enzymic hydrolysis of nucleoside diphosphates and ρ-nitrophenyl phosphate in normal and cortisone-treated rats. J Endocrinol 1966, 36:115-124.
88. Munkonda MN, Pelletier J, Ivanenkov VV, Fausther M, Tremblay A, Kunzli B, Kirley TL, Sevigny J. Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3: partial characterization of the inhibitory epitope and potential applications. FEBS J 2009, 276:479-496.
89. Sevigny J, Cote YP, Beaudoin AR. Purification of pancreas type-I ATP diphosphohydrolase and identification by affinity labelling with the 5′-p-fluorosulphonylbenzoyladenosine ATP analogue. Biochem J 1995, 312:351-356.
90. Lavoie EG, Fausther M, Kauffenstein G, Kukulski F, Kunzli BM, Friess H, Sevigny J. Identification of the ectonucleotidases expressed in mouse, rat, and human Langerhans islets: potential role of NTPDase3 in insulin secretion. Am J Physiol Endocrinol Metab 2010, 299:E647-E656.
91. Tan C, Salehi A, Svensson S, Olde B, Erlinge D. ADP receptor P2Y(13) induce apoptosis in pancreatic β-cells. Cell Mol Life Sci 2010, 67:445-453.
92. Lee DH, Kim EG, Park KS, Jeong SW, Kong ID, Lee JW. Characteristics of P2X7-like receptor activated by adenosine triphosphate in HIT-T15 cells. Pancreas 2007, 35:53-62.
93. Hennigs JK, Seiz O, Spiro J, Berna MJ, Baumann HJ, Klose H, Pace A. Molecular basis of P2-receptor-mediated calcium signaling in activated pancreatic stellate cells. Pancreas 2011, 40:740-746.